FHTX vs SHW · rev $19.3M vs P/E 29, rev $12.46B
Foghorn Therapeutics Inc (FHTX) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
FHTX currently screens at market cap $237.8M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the FHTX and SHW stock pages for the full models.
Not investment advice.